Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/42274Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.referee | Liehr, Uwe-Bernd | - |
| dc.contributor.referee | Paprottka, Philipp Marius | - |
| dc.contributor.referee | Hoffmann, Ralf-Thorsten | - |
| dc.contributor.author | Mohnike, Konrad | - |
| dc.date.accessioned | 2021-12-14T12:46:02Z | - |
| dc.date.available | 2021-12-14T12:46:02Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.uri | https://opendata.uni-halle.de//handle/1981185920/44228 | - |
| dc.identifier.uri | http://dx.doi.org/10.25673/42274 | - |
| dc.language.iso | ger | - |
| dc.publisher | Otto-von-Guericke-Universität Magdeburg | - |
| dc.rights.uri | https://creativecommons.org/licenses/by-sa/4.0/ | - |
| dc.subject | Interstitielle Strahlentherapie | ger |
| dc.subject | Brachytherapie | ger |
| dc.subject | Krebs | ger |
| dc.subject.ddc | 615.842 | - |
| dc.title | Interventionell onkologische Therapie mit der interstitiellen 192Iridium HDR- Brachytherapie von Malignomen des Oberbauches : Was wir wissen : Dosiseffekte und Sicherheit, Tumorkontrolle und Prognose, Variabilität und klinische Relevanz : [kumulative Habilitation] | ger |
| dcterms.dateAccepted | 2021 | - |
| dc.type | Habilitation | - |
| dc.identifier.urn | urn:nbn:de:gbv:ma9:1-1981185920-442289 | - |
| local.versionType | acceptedVersion | - |
| local.publisher.universityOrInstitution | Otto-von-Guericke-Universität Magdeburg | - |
| local.openaccess | true | - |
| local.accessrights.dnb | free | - |
| Appears in Collections: | Medizinische Fakultät | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Habilitation_Dr._Konrad_Mohnike.pdf | 32.11 MB | Adobe PDF |  View/Open |